ELVNEnliven Therapeutics, Inc.

$41.50+91% 1Y

Is the price fair?

What ELVN's price assumes

Price / book
3.75

Price / book · as of 2026-Q2

Details›
Price / bookas of 2026-Q2
3.75
Market capitalisation73.3 million shares, counted Jul 28, 2026
$3.04B

Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.

On our screens:Most shorted stocks